Works matching IS 0008543X AND DT 2014 AND VI 120 AND IP 22


Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    14
    15
    16
    17
    18
    19

    Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 22, p. 3575, doi. 10.1002/cncr.28892
    By:
    • Barton, Debra L.;
    • Thanarajasingam, Gita;
    • Sloan, Jeff A.;
    • Diekmann, Brent;
    • Fuloria, Jyotsna;
    • Kottschade, Lisa A.;
    • Lyss, Alan P.;
    • Jaslowski, Anthony J.;
    • Mazurczak, Miroslaw A.;
    • Blair, Scott C.;
    • Terstriep, Shelby;
    • Loprinzi, Charles L.
    Publication type:
    Article
    20
    21
    22
    23
    24

    A brick in the wall.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 22, p. 3586, doi. 10.1002/cncr.28918
    By:
    • Nogueira‐Rodrigues, Angelica;
    • Ferreira, Carlos G.
    Publication type:
    Article
    25
    26